These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10561831)

  • 1. Effective gene transfer using viral vectors based on SV40.
    Strayer DS
    Methods Mol Biol; 2000; 133():61-74. PubMed ID: 10561831
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of recombinant SV40 vectors for gene transfer.
    Strayer DS; Lamothe M; Wei D; Milano J; Kondo R
    Methods Mol Biol; 2001; 165():103-17. PubMed ID: 11217380
    [No Abstract]   [Full Text] [Related]  

  • 3. A packaging system for SV40 vectors without viral coding sequences.
    Fang B; Koch P; Bouvet M; Ji L; Roth JA
    Anal Biochem; 1997 Dec; 254(1):139-43. PubMed ID: 9398356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions.
    Rund D; Dagan M; Dalyot-Herman N; Kimchi-Sarfaty C; Schoenlein PV; Gottesman MM; Oppenheim A
    Hum Gene Ther; 1998 Mar; 9(5):649-57. PubMed ID: 9551613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel integrase-defective lentiviral episomal vectors for gene transfer.
    Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A
    Hum Gene Ther; 2004 Apr; 15(4):361-72. PubMed ID: 15053861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants.
    Arad U; Ben-Nun-Shaul O; El-Latif MA; Nissim O; Oppenheim A
    Virology; 2002 Dec; 304(2):155-9. PubMed ID: 12504557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.
    Kimchi-Sarfaty C; Gottesman MM
    Curr Pharm Biotechnol; 2004 Oct; 5(5):451-8. PubMed ID: 15544493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The functional activity of the regulator region of virus SV40 integrated into recombinant plasmids].
    Landau SM; Kolomiets LI; Tikhonov AV
    Tsitol Genet; 1994; 28(2):55-62. PubMed ID: 7941017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
    Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
    J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells.
    Strayer DS; Kondo R; Milano J; Duan LX
    Gene Ther; 1997 Mar; 4(3):219-25. PubMed ID: 9135735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors.
    Huylebroeck D; Maertens G; Verhoeyen M; Lopez C; Raeymakers A; Jou WM; Fiers W
    Gene; 1988 Jun; 66(2):163-81. PubMed ID: 2844629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method.
    Arad U; Zeira E; El-Latif MA; Mukherjee S; Mitchell L; Pappo O; Galun E; Oppenheim A
    Hum Gene Ther; 2005 Mar; 16(3):361-71. PubMed ID: 15812231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of SV40 proteins in insect cells and in vitro packaging of virions and pseudovirions.
    Sandalon Z; Oppenheim A
    Methods Mol Biol; 2001; 165():119-28. PubMed ID: 11217381
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing the production of recombinant SV40 vectors.
    Vera M; Prieto J; Strayer DS; Fortes P
    Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen.
    Brady J; Bolen JB; Radonovich M; Salzman N; Khoury G
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2040-4. PubMed ID: 6201850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titering replication-defective virus for use in gene transfer.
    Strayer DS; Duan LX; Ozaki I; Milano J; Bobraski LE; Bagasra O
    Biotechniques; 1997 Mar; 22(3):447-50. PubMed ID: 9067019
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of gene expression using simian virus 40 vectors.
    Subramani S; Southern PJ
    Anal Biochem; 1983 Nov; 135(1):1-15. PubMed ID: 6322609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40-based Escherichia coli shuttle vectors infectious for monkey cells.
    Menck CF; Sarasin A; James MR
    Gene; 1987; 53(1):21-9. PubMed ID: 3036664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.